| Impact of Atogepant on Patient Functioning Among Participants With Episodic Migraine: Migraine-Specific Quality of Life Questionnaire v2. 1 Item-Level Analysis (P8-12.002) R Lipton, P Gandhi, D Buse, M Matharu, K Carr, B Dabruzzo, Y Liu, ... Neurology 102 (17_supplement_1), 2432, 2024 | | 2024 |
| Gaps in Acute Treatment Optimization in Participants with Migraine: Results from the US Cohort of the Chronic Migraine Epidemiology and Outcomes—International (CaMEO-I) Study … T Schwedt, D Buse, S Hutchinson, K Fanning, C Schlacher, JCD Lama, ... Neurology 102 (17_supplement_1), 6154, 2024 | | 2024 |
| Real-world Switching Rates of Atogepant Are Lower than CGRP Monoclonal Antibodies (mAbs) in Patients with Migraine Using Claims Database (P4-12.008) R Lipton, P Gandhi, L Wilson, S Ayton, K Umashankar, M Duan, J Ailani Neurology 102 (17_supplement_1), 3503, 2024 | | 2024 |
| Ictal and Interictal Disability Associated with a Change in Migraine-related Stigma Questionnaire (MiRS) Over 1-year Among People with Migraine: Results from the OVERCOME (US … R Shapiro, E Muenzel, D Buse, E Seng, A Sheikhi, S Ashina, R Nicholson, ... Neurology 102 (17_supplement_1), 5305, 2024 | | 2024 |
| Combined Efficacy and Safety of AXS-07 (MOSEICTM Meloxicam and Rizatriptan) in Two Phase 3 Clinical Trials (P7-12.002) S Tepper, R Lipton, A Chhabra, C Streicher, G Parks, H Tabuteau Neurology 102 (17_supplement_1), 5219, 2024 | | 2024 |
| Normative data for the Digit Symbol Substitution for diverse Hispanic/Latino adults: Results from the Study of Latinos‐Investigation of Neurocognitive Aging (SOL‐INCA) A Morlett Paredes, W Tarraf, K Gonzalez, AM Stickel, LV Graves, ... Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 16 (2 …, 2024 | | 2024 |
| Preventive treatment of migraine RB Lipton CONTINUUM: Lifelong Learning in Neurology 30 (2), 364-378, 2024 | 2 | 2024 |
| Persistance de la réponse au traitement par eptinezumab pendant 24 semaines chez les patients atteints de migraine en échec aux traitements préventifs antérieurs CD Rajca, M Ashina, R Lipton, J Ailani, J Versijpt, B Sperling, A Ettrup Revue Neurologique 180, S27-S28, 2024 | | 2024 |
| “Cognitive” Criteria in Older Adults With Slow Gait Speed: Implications for Motoric Cognitive Risk Syndrome CO Nester, Q Gao, C Wang, MJ Katz, RB Lipton, J Verghese, LA Rabin The Journals of Gerontology, Series A: Biological Sciences and Medical …, 2024 | | 2024 |
| A Taxonomy of Data Synthesis: A Tutorial ED Beck, EC Willroth, JAM Delius, D Bennett, LL Barnes, B James, ... OSF, 2024 | | 2024 |
| Guidelines of the International Headache Society for controlled trials of pharmacological preventive treatment for persistent post-traumatic headache attributed to mild … H Ashina, HC Diener, C Tassorelli, AI Scher, RB Lipton, P Pozo-Rosich, ... Cephalalgia 44 (3), 03331024241234068, 2024 | | 2024 |
| Evaluation of outcomes of calcitonin gene-related peptide (CGRP)-targeting therapies for acute and preventive migraine treatment based on patient sex F Porreca, E Navratilova, J Hirman, AM van den Brink, RB Lipton, ... Cephalalgia 44 (3), 03331024241238153, 2024 | 2 | 2024 |
| Personality predictors of dementia diagnosis and neuropathological burden: An individual participant data meta‐analysis ED Beck, T Yoneda, BD James, DA Bennett, J Hassenstab, MJ Katz, ... Alzheimer's & Dementia 20 (3), 1497-1514, 2024 | 3 | 2024 |
| Connections between reproductive health and cognitive aging among women enrolled in the HCHS/SOL and SOL‐INCA AM Stickel, W Tarraf, S Kuwayama, B Wu, EE Sundermann, LC Gallo, ... Alzheimer's & Dementia 20 (3), 1944-1957, 2024 | | 2024 |
| A randomized, open‐label, 5‐period crossover study evaluating the pharmacokinetics and safety of a single dose of intranasal dihydroergotamine (DHE) powder (STS101 … RB Lipton, D Albrecht, M Bermudez, J Hu, E Hussey, J Levy Headache: The Journal of Head and Face Pain, 2024 | 1 | 2024 |
| Plasma Biomarkers as Predictors of Progression to Dementia in Individuals with Mild Cognitive Impairment BT Nallapu, KK Petersen, RB Lipton, C Davatzikos, A Ezzati Journal of Alzheimer's Disease, 1-16, 2024 | 2 | 2024 |
| Does the Cognitive Change Index Predict Future Cognitive and Clinical Decline? Longitudinal Analysis in a Demographically Diverse Cohort CO Nester, Q Gao, MJ Katz, JA Mogle, C Wang, CA Derby, RB Lipton, ... Journal of Alzheimer's Disease, 1-14, 2024 | | 2024 |
| Migraine-Related Stigma and Its Relationship to Disability, Interictal Burden, and Quality of Life: Results of the OVERCOME (US) Study RE Shapiro, RA Nicholson, EK Seng, DC Buse, ML Reed, AJ Zagar, ... Neurology 102 (3), e208074, 2024 | 6 | 2024 |
| Health care resource utilization and costs associated with diagnosed medication overuse headache and potential acute medication overuse in individuals with migraine AR Shewale, JA Brandenburg, K Burslem, RB Lipton, JA Doshi Cephalalgia 44 (2), 03331024241235139, 2024 | | 2024 |
| International Classification of Headache Disorders-4 – Work in Progress 1 PJ Goadsby, S Evers, AA Gelfand, RB Lipton, A May, P Pozo-Rosich, ... Cephalalgia 44 (2), 03331024241233937, 2024 | | 2024 |
Dawn C. BuseAlbert Einstein College of Medicine of Yeshiva University在 montefiore.org 的电子邮件经过验证
